[SERM and quality of bone]
- PMID: 15577138
[SERM and quality of bone]
Abstract
Now, we can prevent osteoporotic fractures by improvement of bone strength. It became clear that not only the increase of bone mineral density but also the improvement of bone quality are important factors for the mechanisms of preventing fractures. Measuring bone metabolism markers is contributing to evaluate bone quality. We presume SERM demonstrates a sustained fracture preventive effect through 4 yrs by normalizing the bone metabolism of postmenopausal women with osteoporosis.
Similar articles
-
[Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].Clin Calcium. 2004 Oct;14(10):73-80. Clin Calcium. 2004. PMID: 15577135 Review. Japanese.
-
[Relationship between changes in biochemical markers of bone turnover and prediction value of fracture risk].Clin Calcium. 2004 Oct;14(10):39-46. Clin Calcium. 2004. PMID: 15577130 Review. Japanese.
-
[Contribution of bone quality to fracture risk].Clin Calcium. 2004 Oct;14(10):33-8. Clin Calcium. 2004. PMID: 15577129 Review. Japanese.
-
[Evidence of raloxifene on postmenopausal osteoporosis].Nihon Rinsho. 2007 Nov 28;65 Suppl 9:374-80. Nihon Rinsho. 2007. PMID: 18161135 Review. Japanese. No abstract available.
-
[Effects of SERMs on bone health. Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].Clin Calcium. 2010 Mar;20(3):315-21. Clin Calcium. 2010. PMID: 20190360 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical